Article
NGR4 and ERBB4 as Promising Diagnostic and Therapeutic Targets for Metabolic Disorders
6 Jun 2023
Abstract excerpt
Obese individuals are at high risk for developing type 2 diabetes mellitus, cardiovascular diseases, and nonalcoholic fatty liver disease. The aim of this review was to analyze the scientific literature and databases to reveal the fundamental role of neuregulin 4 (NRG4) and its receptors in the development of obesity-associated metabolic disorders. This review demonstrates that NRG4 and its receptors are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
